Anúncio
Anúncio
PTCT
PTC Therapeutics, Inc.
76.69
USDPatrocinado
+0.73
+0.96%
02 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
75.50
-1.19
-1.55%
Relatórios de Lucros PTCT
Rácio de surpresa positiva
PTCT separação 14 de 40 últimas estimativas.
35%
Próximo Relatório
Data do Próximo Relatório
25 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$241.29M
/-$0.55
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+14.35%
/-375.00%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+13.19%
/-74.42%
PTC Therapeutics, Inc. earnings per share and revenue
On 04 de nov. de 2025, PTCT reported earnings of 0.20 USD per share (EPS) for Q3 25, beating the estimate of -1.39 USD, resulting in a 114.33% surprise. Revenue reached 211.01 milhão, compared to an expected 188.96 milhão, with a 11.67% difference. The market reacted with a +5.98% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 17 analistas forecast an EPS of -0.55 USD, with revenue projected to reach 241.29 milhão USD, implying an diminuir of -375.00% EPS, and aumentar of 14.35% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
22 de dez. de 2025 Para Q4 25
Estimativa
-$0.57
Real
-$0.73
Surpresa
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
19 de dez. de 2025 Para Q4 25
Estimativa
-$0.25
Real
-$0.19
Surpresa
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
What were PTC Therapeutics, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, PTC Therapeutics, Inc. reported EPS of $0.20, beating estimates by 114.33%, and revenue of $211.01M, 11.67% above expectations.
How did the market react to PTC Therapeutics, Inc.'s Q3 2025 earnings?
The stock price moved up 5.98%, changed from $67.72 before the earnings release to $71.77 the day after.
When is PTC Therapeutics, Inc. expected to report next?
The next earning report is scheduled for 25 de fev. de 2026.
What are the forecasts for PTC Therapeutics, Inc.'s next earnings report?
Based on 17
analistas, PTC Therapeutics, Inc. is expected to report EPS of -$0.55 and revenue of $241.29M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio